Goat anti-Human IgG Fc - Affinity Pure, TRITC Conjugate, min x w/human IgA + IgM

Goat anti-Human IgG Fc - Affinity Pure, TRITC Conjugate, min x w/human IgA + IgMGoat anti-Human IgG Fc - Affinity Pure, TRITC Conjugate, min x w/human IgA + IgM

Downloads

Safety Data Sheet

Download Safety Data Sheet

Specification Sheets

Price:
$101.57
Part Number:
GtxHu-004-FRHOX
Concentration:
1.0 mg/ml (E 1% at 280 nm = 13.0)
Amount:
1.0 mg
Conjugate:
Tetramethylrhodamine-5-isothiocyanate (TRITC) Amax = 550 nm; Emax = 570 nm
Form:
Lyophilized
Purification:
Affinity purified using solid phase Human IgG
Purity:
Affinity purified antibody is > 95% based on SDS-PAGE
Host:
Goat
Immunogen:
Purified Human IgG, Fc fragment
Buffer:
10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 1 % (w/v) BSA, Protease/IgG free
Preservative:
0.05% (w/v) Sodium Azide
Reconstitution:
Rehydrate with 1.1 ml of deionized water and let stand 30 minutes at room temperature to dissolve. (Product has been overfilled to ensure complete recovery.) Centrifuge to remove any particulates. Prepare fresh working dilution daily.
Storage:
2-8 °C
Shelf Life:
1 year from date of receipt. Prepare working dilution prior to use and then discard.
Specificity:
Based on IEP, this antibody reacts with:
  • heavy (γ) chains on human IgG
Cross Reactivity:
Based on IEP, no reactivity is observed to:
  • non-immunoglobulin human serum immunoglobulins
  • light chains on all human immunoglobulins
  • human IgA or IgM
Country of Origin:
Goat serum was obtained from healthy animals of US origin and under the care of a registered veterinarian.
Applications:
  • Flow Cytometry
  • Immunofluorescence
  • ELISA
  • Immunomicroscopy
Disclaimer:
For in vitro Laboratory Use Only. Not for diagnostic or therapeutic use. Not for human or animal consumption. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license under any patent of ImmunoReagents, Inc. Product may not be resold or modified for resale without prior written approval of ImmunoReagents, Inc.

ImmunoReagents University: